Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page
- Check2 days agoChange DetectedFooter now displays Revision: v3.6.6, replacing the previous revision text, indicating a site version update. The related topics section has been reduced by removing Prostate cancer and MedlinePlus Genetics, affecting only ancillary metadata rather than the study content.SummaryDifference0.2%

- Check9 days agoChange DetectedThe Related Topics section now includes Prostate cancer and MedlinePlus Genetics, providing quick access to disease background and genetics resources.SummaryDifference0.2%

- Check16 days agoChange DetectedThe related topics section including Prostate cancer and MedlinePlus Genetics was removed, reducing the related-resource links displayed on the study page. This changes how readers navigate to external resources rather than altering the study data.SummaryDifference0.2%

- Check23 days agoChange DetectedA new MedlinePlus Genetics related topic link for Prostate cancer was added under related topics, and the site revision label updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, signaling a new version of the study page. This appears to be a behind-the-scenes update rather than a substantive modification to the study content or results.SummaryDifference0.1%

- Check52 days agoChange DetectedThe Related Topics header and its links for Prostate cancer and MedlinePlus Genetics were removed, altering the page's navigation to related resources.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.